Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pfizer
Pfizer
Page 10 of 37
Newsletters
The world has changed but many boards ‘have not moved on’
By
David Meyer
and
Alan Murray
November 19, 2021
Newsletters
What the CEOs of Walgreens, Hilton and Progressive think about the Great Resignation
By
David Meyer
and
Alan Murray
November 18, 2021
Newsletters
Resiliency, climate and China: Lessons from Day 2 of the Fortune CEO Initiative
By
David Meyer
and
Alan Murray
November 17, 2021
Health
Pfizer seeks emergency FDA authorization for COVID-19 pill
By
Matthew Perrone
and
The Associated Press
November 16, 2021
Conferences
How Pfizer’s CEO ruthlessly cut bureaucracy to deliver a COVID vaccine in record time
By
Alyssa Newcomb
November 16, 2021
Health
Here are the side effects you can expect from a COVID-19 vaccine booster shot
By
Kylie Logan
November 16, 2021
Health
Pfizer pledges equitable access to COVID-19 pill through new licensing agreement
By
Grady McGregor
November 16, 2021
Health
Pfizer’s COVID-19 vaccine generated the strongest immune response in study of 4 jabs
By
Jason Gale
and
Bloomberg
November 15, 2021
Health
We won’t have COVID vaccines for kids under 5 until 2022, according to Pfizer
By
Brett Haensel
November 12, 2021
Health
The U.S. administered more COVID shots this week than it has since spring
By
Nicolas Rapp
and
Erika Fry
November 10, 2021
International
Germany cautions pregnant women and people under 30 get the Pfizer shot over Moderna
By
Tim Loh
and
Bloomberg
November 10, 2021
Health
FDA considering authorizing Pfizer’s COVID vaccine boosters for all U.S. adults, possibly before Thanksgiving
By
Kylie Logan
November 9, 2021
International
Investors are betting that Pfizer’s ‘game-changing’ antiviral pill will reduce demand for COVID vaccines
By
Grady McGregor
November 8, 2021
Health
Pfizer says its COVID pill cuts rates of death and hospitalization by 89%, sending shares skyward
By
David Meyer
November 5, 2021
Health
Nearly 20 months into the global pandemic, infections are again on the rise
By
Erika Fry
and
Nicolas Rapp
November 3, 2021
Most Popular
Retail
Trump just declared December 26th a national holiday. What's open and closed?
By
Dave Smith
Real Estate
Mark Zuckerberg gifted noise-canceling headphones to his Palo Alto neighbors because of the nonstop construction around...
By
Dave Smith
Success
As millions of Gen Zers face unemployment, CEOs of Amazon, Walmart, and McDonald's say opportunity is still there—if...
By
Preston Fore